News

Established in 2011 in response to the changing global economy and an increasing demand for world-class technologies in Asia and operating out of offices in in Hong Kong and Nanjing of Jiangsu province, WD Asia is the first permanent technology commercialization entity in Asia ever created by a Canadian organization.

Over the years, WD Asia has achieved a series of successes in facilitating licensing deals, research collaborations, and the creation of start-ups for London’s researchers valued at $30 million CAD total.

By early 2019, with the support from many strategic partners and years of development, WD Asia has grown into a successful professional services provider dedicated to helping research institutions and high-tech small and medium sized enterprises (SMEs) across Ontario form intellectual property and innovation partnerships in China.

Western Medical Innovation Fellows Bashar Yafouz, Wagner H. Souza, and Maryam Majedi participated in the fifth annual Proteus Innovation Competition and through their abstract, business plan proposal and business pitch grabbed one of the top three $5,000 prizes and the chance to license and market the technology.

The Fellows, part of Western’s Medical Innovation Fellowship (MIF) program which immerses early career scientists, engineers and clinicians in a training and research-heavy environment with the goal of developing future leaders and innovators of world-class medical technologies.

The skills learned from their program gave them a competitive advantage when they decided to participate in the Proteus Innovation Competition – an intense, four-month competition that takes three newly developed technologies from Ontario research institutions and challenges teams to plan their commercialization. It is a partnership among WORLDiscoveries, Western Entrepreneurship, Western Research Parks, TechAlliance, McMaster University and the University of Windsor.

Becoming an entrepreneur takes a lot of ambition. The best time to start was yesterday. The next best time to start is May 5!

The ‘Master the Entrepreneur Skillset’ is a six-week online program that will introduce you to the tools and mindset required to succeed as an entrepreneur. You do not need an idea or a pre-existing team to join the program. Just an open mind and a willingness to learn and explore your full potential. For a limited time, our program is being offered for free to Western alumni, students, faculty, and staff (all tuition and fees waived). Space is limited. Sign-up today to claim your spot.

Our team has compiled a list of funding opportunities to help combat the impacts of COVID-19. This list will be updated as opportunities become available.

The Ontario government has set up an Expert Panel on Intellectual Property with the mandate of the panel being to protect home-grown innovation and maximize commercialization. The panel is looking at various opportunities to improve in the post-secondary education sector including at incubators, accelerators, technology transfer offices, and innovation centres.

The panel is looking to make recommendations to the Ministry of Training, Colleges and Universities to improve the generation and commercialization of research and intellectual property.

The Western Medical Innovation Fellowship (MIF) immerses talented young scientists, engineers and clinicians in training and research environments that build innovation leaders and create novel medical technologies. Now at the end of their 10.5 month program, the 2018-19 Western Medical Innovation Fellows are looking to move onto their next adventure – entrepreneurship. As part of their program, the fellows consulted with clinicians across the local healthcare industry and developed two projects to address needs they discovered throughout the process that fit within their areas of expertise. These two projects are being spun-off into two London-based innovative medical startups thanks to the support of BURST, an incubation program for high-potential medical technology startups through the TechAlliance of Southwestern Ontario.

Duncan Hunter chokes up a little when it is suggested that work he began at Western three decades ago will now, finally, be applied to saving hundreds of lives. “It’s a good thing,” said the Chemistry professor emeritus after a long pause. “It took 30 years and had its ups and downs. So, yes, it’s emotional.”

Last week, the U.S. Food and Drug Administration (FDA) approved the use of Azedra, a new compound developed by Progenics Pharmaceuticals Inc., for patients with rare tumours of the adrenal glands.